Several immune checkpoint molecules, such as programmed cell death 1 (PD-1) and its ligand (PD-L1), along with cytotoxic T lymphocyte antigen 4 (CTLA-4), have been identified as being connected to the development of an immunosuppressive TME and immune evasion in various types of cancer [2]. This evidence concerns the gene PDCD1 and cancer.